The LRCB (KU Leuven) is interested in studying RNA metabolism in cancer. In particular, we aim at characterising long non-coding RNAs important for cancer progression. Towards this we apply cutting edge molecular biology and biochemistry techniques coupled to in vivo and ex vivo preclinical studies, with the ultimate goal of identifying promising therapeutic targets. The laboratory hosts also Trace, a state-ofthe-art facility offering a unique collection of >150 well-annotated patient-derived models, belonging to 11 tumour types.

KU Leuven is an exciting, interdisciplinary university hosting excellent facilities and research groups and providing extensive opportunities for training.

Profile
We are looking for a motivated postdoctoral researcher to work on lncRNAs in translational regulation and cancer therapy resistance.

The ideal candidate has the following qualifications:
• PhD in biochemistry/biotechnology, biomedical sciences, cell biology, bioengineering, or related disciplines
• A strong expertise in cancer biology.
• Experience with in vivo cancer modelling.
• Expertise in omics data analysis and/or immunology is a plus.

We value diversity in skill sets and encourage applicants with a keen interest in contributing to groundbreaking research at the intersection of RNA and Cancer Biology.
We look for applicants with a solid publication record and strong scientific drive.

We offer
The LRCB has a track record in RNA medicine. Check out our laboratory and publications. We provide a stimulating and supportive environment to help you continue pursuing your scientific career. Our lab greatly values diverse standpoints and promotes an inclusive environment in which everyone feels welcome and respected.

KU Leuven has 600-year experience in education, groundbreaking research an innovation.

Our laboratory is strategically located at the Gasthuisberg (medical) campus of the KU Leuven (Faculty of Medicine) in close proximity to the UZ Leuven clinic and with VIB
Center for Cancer Biology. This is a unique opportunity to bring basic RNA biology discoveries into preclinical and early clinical stage.

The candidate is expected to start early in 2025. We offer a 1-year contract extendable to 4 years. Interested candidates should contact the PI: eleonora.leucci@kuleuven.be and include:
• Your CV
• a cover letter stating your reasons for your interest in this position.
• the contact details of two references you collaborated with professionally for at least 8 months.